- Start date
- 16 Sep 2024
- End date
- 16 Sep 2024
- Location
- Oviedo Auditorium - Hall 3
Programme
13:00
Welcome and introduction
Ticiana Leal, Atlanta, GA, USA
13:10
Alternating electric fields in cancer therapy: Mode of action and principles of cytotoxicity
Carsten Hagemann, Würzburg, Germany
13:25
Clinical evidence for efficacy & safety of electric fields therapeutic applications for patients with advanced non-small cell lung cancer
Ticiana Leal, Atlanta, GA, USA
13:40
Emerging clinical evidence on the efficacy of electric fields in controlling sanctuary metastatic site
Minesh Mehta, Miami, FL, USA
13:55
Research insights in future developments of alternating electric field applications in oncology and potential for combination with systemic agents and irradiation
Gerben Borst, Manchester, United Kingdom
14:10
Q&A and discussion
All speakers
14:25
Concluding remarks
Gerben Borst, Manchester, United Kingdom
Learning objectives
- To understand the mechanism of action of electric fields and their synergy with other anticancer modalities in oncology
- To be informed on the latest clinical evidence for efficacy and safety of electric fields as monotherapy and in combination for the management of patients with advanced non-small cell lung cancer
- To be informed on the efficacy of electric fields in controlling tumour growth in sanctuary metastatic sites
- To obtain insights on ongoing research in future developments of electric fields applications in thoracic oncology
